MEEI drops litigation against QLT & Novartis
Litigation proceedings initiated by the Massachusetts Eye and Ear Infirmary (MEEI) in 2001 against QLT and Novartis Ophthalmics, have been settled.
Litigation proceedings initiated by the Massachusetts Eye and Ear Infirmary (MEEI) in 2001 against QLT and Novartis Ophthalmics, have been settled.
Under the terms of the agreement, MEEI will dismiss its claim that QLT and Novatis had infringed US Patent #6,225,303 and QLT and Novartis will dismiss its counterclaims against MEEI and named MEEI researchers.
However, a further patent lawsuit, brought in 2000 by MEEI against QLT, has yet to be resolved.
Newsletter
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
Recent Videos
Sheng Lim, MD, FRCOphth, brings data from the CONCEPT study to the ASCRS meeting
A panel discussion on extended treatment intervals in retinal therapy breaks the mold at COPHy 2025
How embracing opposition sends clinicians home from COPHy with more useful takeaways
AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Impact of Durable Therapies on Patients and Clinics and Monitoring Strategies
Angiogenesis 2025: The global forecast for AI-driven home OCT
Strategies for Loading Dose Sse for Treatment-Naive and Switch Patients
Perspectives on the Usefulness of Real-world Data
Veterinary ophthalmology can foster insights and progress in glaucoma care
I. Paul Singh, MD, says artificial intelligence will help glaucoma specialists make decisions
Related Content
